BRSK2
Serine/threonine-protein kinase BRSK2
Also known as: BRSK2_HUMAN, C11orf7, PEN11B, SAD-A, STK29
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IWQ3
- Gene
- BRSK2
- Ensembl
- ENSG00000174672
- Chromosome
- 11
- Canonical length
- 736 aa
- Protein class
- Enzymes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Golgi apparatus
OverviewNCBI Gene
Enables several functions, including ATP binding activity; ATPase binding activity; and magnesium ion binding activity. Involved in several processes, including G2/M transition of mitotic cell cycle; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; and regulation of insulin secretion involved in cellular response to glucose stimulus. Located in centrosome and endoplasmic reticulum. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
736 residues, UniProt reviewed canonical sequence.
>Q8IWQ3|BRSK2
1 MTSTGKDGGA QHAQYVGPYR LEKTLGKGQT GLVKLGVHCV TCQKVAIKIV NREKLSESVL
61 MKVEREIAIL KLIEHPHVLK LHDVYENKKY LYLVLEHVSG GELFDYLVKK GRLTPKEARK
121 FFRQIISALD FCHSHSICHR DLKPENLLLD EKNNIRIADF GMASLQVGDS LLETSCGSPH
181 YACPEVIRGE KYDGRKADVW SCGVILFALL VGALPFDDDN LRQLLEKVKR GVFHMPHFIP
241 PDCQSLLRGM IEVDAARRLT LEHIQKHIWY IGGKNEPEPE QPIPRKVQIR SLPSLEDIDP
301 DVLDSMHSLG CFRDRNKLLQ DLLSEEENQE KMIYFLLLDR KERYPSQEDE DLPPRNEIDP
361 PRKRVDSPML NRHGKRRPER KSMEVLSVTD GGSPVPARRA IEMAQHGQRS RSISGASSGL
421 STSPLSSPRV TPHPSPRGSP LPTPKGTPVH TPKESPAGTP NPTPPSSPSV GGVPWRARLN
481 SIKNSFLGSP RFHRRKLQVP TPEEMSNLTP ESSPELAKKS WFGNFISLEK EEQIFVVIKD
541 KPLSSIKADI VHAFLSIPSL SHSVISQTSF RAEYKATGGP AVFQKPVKFQ VDITYTEGGE
601 AQKENGIYSV TFTLLSGPSR RFKRVVETIQ AQLLSTHDPP AAQHLSDTTN CMEMMTGRLS
661 KCGSPLSNFF DVIKQLFSDE KNGQAAQAPS TPAKRSAHGP LGDSAAAGPG PGGDAEYPTG
721 KDTAKMGPPT ARREQPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BRSK2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 97 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 97 nTPM
- cerebellum: 97 nTPM
- cerebral cortex: 69 nTPM
- hippocampal formation: 47 nTPM
- amygdala: 40 nTPM
- basal ganglia: 36 nTPM
Single-cell type
- retinal bipolar cells: 68 nCPM
- brain excitatory neurons: 62 nCPM
- pancreatic acinar cells: 47 nCPM
- brain inhibitory neurons: 47 nCPM
- retinal amacrine cells: 46 nCPM
- oligodendrocyte progenitor cells: 45 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 138 nTPM
- cerebellum: 121 nTPM
- hippocampal formation: 99 nTPM
- white matter: 95 nTPM
- basal ganglia: 86 nTPM
- amygdala: 81 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about BRSK2.
Disease | GeneticClinVar
33 pathogenic / likely-pathogenic of 333 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal dominant non-syndromic intellectual disability
- Inborn genetic diseases
- BRSK2-related disorder
- Neurodevelopmental delay
- BRSK2-associated neurodevelopmental disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.33
- gnomAD pLI
- 0.95
- gnomAD missense Z
- 2.95
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin cytoskeleton organization
- axonogenesis
- cell division
- central nervous system neuron differentiation
- ERAD pathway
- establishment of cell polarity
- exocytosis
- G2/M transition of mitotic cell cycle
- intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress
- microtubule cytoskeleton organization involved in establishment of planar polarity
- neuron differentiation
- protein phosphorylation
- regulation of axonogenesis
- regulation of insulin secretion involved in cellular response to glucose stimulus
- regulation of neuron projection development
- regulation of synaptic vesicle clustering
- regulation of retrograde protein transport, ER to cytosol
Molecular functions
- ATP binding
- ATPase binding
- ATPase regulator activity
- magnesium ion binding
- protein kinase binding
- protein serine kinase activity
- protein serine/threonine kinase activity
- tau protein binding
- tau-protein kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BRSK2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BRSK2 as an antibody target. Whether an autoantibody or antibody against BRSK2 could matter depends on whether native BRSK2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BRSK2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BRSK2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...